Han-Soo Keyoung
Director/Board Member chez HUGEL, INC.
Profil
Dr. Han-Soo Keyoung is on the Board of Directors at Hugel, Inc. and I-Mab Bio-tech (Tianjin) Co. Ltd.
Dr. Keyoung was previously employed as a Co-Chief Executive Officer & Director by Genexine, Inc. He received his doctorate degree from Cornell University.
Postes actifs de Han-Soo Keyoung
| Sociétés | Poste | Début |
|---|---|---|
| HUGEL, INC. | Director/Board Member | 01/04/2022 |
I-Mab Bio-tech (Tianjin) Co. Ltd.
 I-Mab Bio-tech (Tianjin) Co. Ltd. BiotechnologyHealth Technology I-Mab Bio-tech (Tianjin) Co., Ltd. engages in the research and development of medicine and biological products. Its business activities include investment information consultation, and health information services. The company was founded on April 19, 2012 and is headquartered in Tianjin, China. | Director/Board Member | - |
Anciens postes connus de Han-Soo Keyoung
| Sociétés | Poste | Fin |
|---|---|---|
| GENEXINE, INC. | Chief Executive Officer | - |
Formation de Han-Soo Keyoung
| Cornell University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| GENEXINE, INC. | Health Technology |
| HUGEL, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
I-Mab Bio-tech (Tianjin) Co. Ltd.
I-Mab Bio-tech (Tianjin) Co. Ltd. BiotechnologyHealth Technology I-Mab Bio-tech (Tianjin) Co., Ltd. engages in the research and development of medicine and biological products. Its business activities include investment information consultation, and health information services. The company was founded on April 19, 2012 and is headquartered in Tianjin, China. | Health Technology |
